NEXOBRID

ANACAULASE-BCDB · Vericel Corporation

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for NEXOBRID, covering 2011-05-10 to 2025-12-03. Get the full timeline:

Most recent: EMA Authorised: NexoBrid (proteolytic enzymes enriched in bromelain) — MediWound Germany GmbH